REVUMENIB vs RIFAMPICIN: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
REVUMENIB vs RIFAMPICIN: Safety Overview
| Metric | REVUMENIB | RIFAMPICIN |
|---|---|---|
| Total FAERS Reports | 371 | 179 |
| Deaths Reported | 49 | 34 |
| Death Rate | 13.2% | 19.0% |
| Hospitalizations | 93 | 79 |
| Average Patient Age | 46.4 yrs | 46.8 yrs |
| % Female Patients | 47.6% | N/A |
| FDA Approval Date | Nov 15, 2024 | N/A |
| Manufacturer | Syndax Pharmaceuticals, Inc. | N/A |
| Route | ORAL | N/A |
| Marketing Status | Prescription | N/A |